Market Research Logo

Global Prenatal Testing Market Analysis & Forecast, 2016-2022

Global Prenatal Testing Market Analysis & Forecast, 2016-2022

Global Prenatal Testing Market Analysis & Forecast, 2016-2022


Executive Summary
1 Research Scope and Methodology
1.1 Scope of the Report
1.2 Global Prenatal Testing Market Research Methodology
1.2.1 Primary Data Sources
1.2.2 Secondary Data Sources
2 Introduction to the Prenatal Testing Market
3 Market Dynamics
3.1 Market Drivers
3.1.1 Emphasis on Early Detection and Prevention
3.1.2 Increasing Genetic and Congenital Disorders
3.1.3 Availability of Advanced Diagnosis and Screening Technologies
3.1.4 Evolving Government Initiatives
3.1.5 Adoption by Physicians: Incorporation of Tests into Clinical Care
3.1.6 Shifting of Reimbursement Policies towards more Genetics Coverage
3.2 Market Challenges
3.2.1 Risk of Ethical Issues and Social Stigma
3.2.2 Lack of Awareness among Consumers
3.2.3 High Cost of Screening and Diagnosis along with the Lack of Accuracy
3.3 Market Opportunities
3.3.1 Availability of Direct to Consumer Tests
3.3.2 Focus toward Pre-Implantation Genetic Diagnosis
4 Competitive Insights
4.1 Key Market Developments & Strategies
4.1.1 New Product Launch, Development and Expansion
4.1.2 Acquisitions, Partnerships and Collaborations
4.1.3 Business Expansion and Others
4.2 Industry Attractiveness
5 Industry Analysis
5.1 Patent Analysis
5.2 Consortiums, Alliances and Regulatory Bodies
5.3 Value Chain Analysis
6 Global Prenatal Testing Market, Analysis & Forecast
6.1 Assumptions & Limitations for Analysis and Forecast of the Global Prenatal Testing Market
6.2 Market Overview
6.3 Global Prenatal Testing Market by Screening Methods
6.3.1 Non-Invasive Prenatal Tests (NIPT)
6.3.1.1 NIPT Market by Geography
6.3.1.2 North America NIPT Market
6.3.1.2.1 Market Share Analysis by Countries
6.3.1.2.1.1 The U.S.
6.3.1.2.1.2 Canada
6.3.1.2.1.3 Mexico
6.3.1.3 Europe NIPT Market
6.3.1.3.1 Market Share Analysis by Countries
6.3.1.3.1.1 Germany
6.3.1.3.1.2 France
6.3.1.3.1.3 Italy
6.3.1.3.1.4 U.K.
6.3.1.3.1.5 Spain
6.3.1.3.1.6 Other European Countries
6.3.1.4 APAC NIPT Market:
6.3.1.4.1 Market Share Analysis by Countries
6.3.1.4.1.1 China
6.3.1.4.1.2 India
6.3.1.4.1.3 Japan
6.3.1.4.1.4 Other APAC Countries
6.3.1.5 Rest of the World NIPT Market
6.3.2 Other Prenatal Screening Tests
6.3.2.1 Cell-Free Fetal DNA Test
6.3.2.2 Maternal Serum Screening (MSS)
6.3.2.3 Nuchal Scan (NT Procedure)
6.3.2.4 Triple Test
6.3.2.5 Quadruple Test
6.4 Global Prenatal Testing Market by Diagnosis Methods
6.4.1 Global Prenatal Diagnosis Market by Test Type
6.4.1.1 Non-Invasive Prenatal Diagnosis Market
6.4.1.1.1 Ultrasonography
6.4.1.1.2 Fetal Cells in Maternal Blood (FCMB)
6.4.1.1.3 Pre-Implantation Genetic Diagnosis
6.4.1.2 Invasive Prenatal Diagnosis Market
6.4.1.2.1 Invasive Test Market by Test Types
6.4.1.2.1.1 Amniocentesis
6.4.1.2.1.2 Chorionic Villus Sampling (CVS)
6.4.1.2.1.3 Other Invasive Tests
6.4.1.2.1.3.1 Fetal Blood Sampling (FBS)
6.4.1.2.1.3.2 Transcervical Retrieval of Trophoblast Cells
6.4.1.2.1.3.3 Embryoscopy and Fetoscopy
6.4.1.2.2 Invasive Test Market by Geography
6.4.1.2.2.1 North America Invasive Test Market
6.4.1.2.2.1.1 Market Share Analysis by Countries
6.4.1.2.2.1.1.1 The U.S.
6.4.1.2.2.1.1.2 Canada
6.4.1.2.2.1.1.3 Mexico
6.4.1.2.2.2 Europe Invasive Test Market
6.4.1.2.2.2.1 Market Share Analysis by Countries
6.4.1.2.2.2.1.1 Germany
6.4.1.2.2.2.1.2 France
6.4.1.2.2.2.1.3 Italy
6.4.1.2.2.2.1.4 U.K.
6.4.1.2.2.2.1.5 Spain
6.4.1.2.2.2.1.6 Other European Countries
6.4.1.2.2.3 APAC Invasive Test Market
6.4.1.2.2.3.1 Market Share Analysis by Countries
6.4.1.2.2.3.1.1 China
6.4.1.2.2.3.1.2 India
6.4.1.2.2.3.1.3 Japan
6.4.1.2.2.3.1.4 Other APAC Countries
6.4.1.2.2.4 Rest of the World Invasive Test Market
6.4.2 Global Prenatal Diagnosis Market by Geography
6.4.2.1 North America
6.4.2.1.1 Market Analysis by Country
6.4.2.2 Europe
6.4.2.2.1 Market Analysis by Country
6.4.2.3 APAC
6.4.2.3.1 Market Analysis by Country
6.4.2.4 Rest of the World (RoW)
7 Company Profiles
7.1 Agilent Technologies
7.1.1 Overview
7.1.2 Financials
7.1.2.1 Financial Summary
7.1.3 SWOT Analysis
7.2 CombiMatrix
7.2.1 Overview
7.2.2 Financials
7.2.2.1 Financial Summary
7.2.3 SWOT Analysis
7.3 Illumina Inc.
7.3.1 Overview
7.3.2 Financials
7.3.2.1 Financial Summary
7.3.3 SWOT Analysis
7.4 LabCorp of America
7.4.1 Overview
7.4.2 Financials
7.4.2.1 Financial Summary
7.4.3 SWOT Analysis
7.5 Natera Inc.
7.5.1 Overview
7.5.2 Financials
7.5.2.1 Financial Summary
7.5.3 SWOT Analysis
7.6 Quest Diagnostics
7.6.1 Overview
7.6.2 Financials
7.6.2.1 Financial Summary
7.6.3 SWOT Analysis
7.7 Roche Holding
7.7.1 Overview
7.7.2 Ariosa Diagnostics
7.7.2.1 Overview
7.7.3 Financials
7.7.3.1 Financial Summary
7.7.4 SWOT Analysis
7.8 Sequenom Inc.
7.8.1 Overview
7.8.2 Financials
7.8.2.1 Financial Summary
7.8.3 SWOT Analysis
7.9 Snapshot of Some Players
7.9.1 Affymetrix, Inc.
7.9.2 Annoroad Diagnostics
7.9.3 Berry Genomics
7.9.4 BGI Diagnostics
7.9.5 Progenity
7.10 List of Other Prominent Players 175 
List of Tables
Table 2.1 Types of Genetic Diseases in Fetuses: An Overview
Table 2.2 Prenatal Testing: Key Technologies
Table 3.1 Live Birth Rate- Risk of Genetic Abnormality/Disorders by Maternal Age
Table 3.2 Average Cost of Non-Invasive Prenatal Test (NIPT)
Table 4.1 New Product Launch, Development and Expansion
Table 4.2 Recent Acquisitions, Partnerships and Collaborations
Table 4.3 Recent Business Expansion and Others
Table 4.4 Key Factors Considered for Threat of New Entrants: Prenatal Testing
Table 4.5 Key Factors Affecting Bargaining Power of Buyers: Prenatal Testing
Table 4.6 Key Factors Affecting the Bargaining Power of Suppliers: Prenatal Testing
Table 4.7 Key Factors Affecting Threat of Substitute Products: Prenatal Testing
Table 4.8 Key Factors Determining Rivalry among Existing Firms: Prenatal Testing
Table 5.1 Example of Some Recent Patents
Table 5.2 Example of Some Regulatory Bodies/Associations/Consortium
Table 6.1 Global Prenatal Screening Market Size, by Test Type, 2015-2022,
Table 6.2 Geographical Analysis of Players and Cost of NIPT
Table 6.3 Global NIPT Screening Market Size, by Geography, 2015-2022,
Table 6.4 NIPT: Recent Key Developments
Table 6.5 Amniocentesis Prenatal Testing Method Snapshot
Table 6.6 North America Prenatal Diagnosis Market Scope Statistics
Table 6.7 North America: Prenatal Diagnosis Market, by Test Type, 2015-2022
Table 6.8 Recent Key Developments in North America
Table 6.9 Europe Prenatal Diagnosis Market Scope Stats
Table 6.10 Europe: Prenatal Diagnosis Market, by Test Type, 2015-2022
Table 6.11 APAC Prenatal Diagnosis Market Scope Stats
Table 6.12 APAC: Prenatal Diagnosis Market, by Test Type, 2015-2022
Table 6.13 Recent Key Developments in APAC
Table 6.14 RoW: Prenatal Diagnosis Market, by Test Type, 2015-2022
Table 6.15 RoW Prenatal Diagnosis Market Scope Stats
Table 7.1 Snapshot of Other Key Players
Table 7.2 List of other Prominent Players
List of Figures
Figure 1 Global Prenatal Testing Market Size, 2015-2022 ($Billion)
Figure 2 Global Prenatal Testing Market Size, by Type, 2015-2022 ($billion)
Figure 3 Global Prenatal Diagnosis Market, by Geography, 2015 and 2022 ($Billion)
Figure 1.1 Global Prenatal Testing Market Scope
Figure 1.2 Research Methodology
Figure 2.1 Prenatal Testing: Key Elements Covered
Figure 2.2 History & Evaluation of Prenatal Testing
Figure 2.3 Prenatal Testing Timeline during Pregnancy (Till Second Trimester)
Figure 2.4 Factors Responsible for Prenatal Testing
Figure 3.1 Market Dynamics for Prenatal Testing
Figure 3.2 Prenatal Testing Market: Key Market Drivers
Figure 3.3 Prenatal Testing: Key Challenges
Figure 3.4 Prenatal Testing: Key Opportunities
Figure 4.1 Recent Market Development Strategy Snapshot Analysis
Figure 4.2 Key Market Developments & Strategies
Figure 4.3 Porter’s Five Forces Analysis
Figure 5.1 Value Chain Analysis
Figure 6.1 Classification of Global Prenatal Testing Market
Figure 6.2 Global Prenatal Testing Market: Opportunity Matrix
Figure 6.3 Global Prenatal Testing Market, by Technique 2015-2022 ($Billion)
Figure 6.4 Example of a Screening Method
Figure 6.5 Global Prenatal Screening Market Size, 2015-2022, ($Billion)
Figure 6.6 Prenatal Screening Methods
Figure 6.7 NIPT Pricing and Market Penetration Analysis
Figure 6.8 NIPT Pricing and Market Size
Figure 6.9 North America: NIPT Market by Countries, 2015-2022 ($Million)
Figure 6.10 The U.S. NIPT Market, 2015-2022 ($Million)
Figure 6.11 Canada NIPT Market, 2015-2022 ($Million)
Figure 6.12 Mexico NIPT Market, 2015-2022 ($Million)
Figure 6.13 Europe: NIPT Market by Countries, 2015-2022 ($Million)
Figure 6.14 Germany NIPT Market, 2015-2022 ($Million)
Figure 6.15 France NIPT Market, 2015-2022 ($Million)
Figure 6.16 Italy NIPT Market, 2015-2022 ($Million)
Figure 6.17 U.K. NIPT Market, 2015-2022 ($Million)
Figure 6.18 Spain NIPT Market, 2015-2022 ($Million)
Figure 6.19 Other European Countries NIPT Market, 2015-2022 ($Million)
Figure 6.20 APAC: NIPT Market by Countries, 2015-2022 ($Million)
Figure 6.21 China NIPT Market, 2015-2022 ($Million)
Figure 6.22 Indian NIPT Market, 2015-2022 ($Million)
Figure 6.23 Japan NIPT Market, 2015-2022 ($Million)
Figure 6.24 Other APAC Countries NIPT Market, 2015-2022 ($Million)
Figure 6.25 ROW NIPT Market, 2015-2022 ($Million)
Figure 6.26 Global Others Screening Test Market, 2015-2022 ($Billion)
Figure 6.27 Factors Responsible for Cell-Free Fatal DNA
Figure 6.28 Cell-Free Fatal DNA Test; Suggested Time for Testing
Figure 6.29 Prenatal Diagnosis Benefits
Figure 6.30 Global Prenatal Diagnosis Market Size, 2015-2022, ($Billion)
Figure 6.31 Prenatal Diagnosis Market by Test Type
Figure 6.32 Global Prenatal Diagnosis Market Share, by Test Type, 2015
Figure 6.33 Global Non-Invasive Prenatal Diagnosis Market, 2015-2022 ($Million)
Figure 6.34 Global Invasive Prenatal Diagnosis Test Market, by Test type, 2015-2022 ($Million)
Figure 6.35 Amniocentesis Schematic Diagram
Figure 6.36 Types of procedure for CVS
Figure 6.37 Types of Chorionic Villus Sampling (CVS) Procedure
Figure 6.38 Methods of Transcervical Cell collection
Figure 6.39 Global Invasive Prenatal Diagnosis Test Market, by Geography, 2015-2022 ($Million)
Figure 6.40 North America: Invasive test Market by Countries, 2015-2022 ($Million)
Figure 6.41 The U.S. Invasive Test Market, 2015-2022 ($Million)
Figure 6.42 Canada Invasive Test Market, 2015-2022 ($Million)
Figure 6.43 Mexico Invasive Test Market, 2015-2022 ($Million)
Figure 6.44 Europe: Invasive Test Market by Countries, 2015-2022 ($Million)
Figure 6.45 Germany Invasive Test Market, 2015-2022 ($Million)
Figure 6.46 France Invasive Test Market, 2015-2022 ($Million)
Figure 6.47 Italy Invasive Test Market, 2015-2022 ($Million)
Figure 6.48 U.K. Invasive Test Market, 2015-2022 ($Million)
Figure 6.49 Spain Invasive Test Market, 2015-2022 ($Million)
Figure 6.50 Other European Countries Invasive Test Market, 2015-2022 ($Million)
Figure 6.51 APAC: Invasive Test Market by Countries, 2015-2022 ($Million)
Figure 6.52 China Invasive Test Market, 2015-2022 ($Million)
Figure 6.53 India Invasive Test Market, 2015-2022 ($Million)
Figure 6.54 Japan Invasive Test Market, 2015-2022 ($Million)
Figure 6.55 Other APAC Countries Invasive Test Market, 2015-2022 ($Million)
Figure 6.56 ROW Invasive Test Market, 2015-2022 ($Million)
Figure 6.57 Global Prenatal Diagnosis Market by Geography
Figure 6.58 Global Prenatal Diagnosis Market, by Geography, 2015-2022 ($Million)
Figure 6.59 North American Market Dynamics
Figure 6.60 Key Players in North American Prenatal Testing Market
Figure 6.61 Key Factors Driving the Prenatal Testing Market in Europe
Figure 6.62 Key Players in European Prenatal Testing Market
Figure 6.63 Key Factors Driving the Prenatal Testing Market in APAC
Figure 6.64 Challenges for Prenatal Testing in APAC
Figure 6.65 Key Players in APAC Prenatal Testing Market
Figure 6.66 Key Factors Driving the Prenatal Testing Market in Row
Figure 6.67 Key Players in RoW Prenatal Testing Market
Figure 7.1 Agilent: Overall Financials, 2013-2015
Figure 7.2 Agilent: Net Revenue by Business Segment, 2013-2015
Figure 7.3 Agilent: Revenue across Different Geographies, 2013-2015
Figure 7.4 Agilent: SWOT Analysis
Figure 7.5 CombiMatrix: Overall Financials, 2013-2015
Figure 7.6 CombiMatrix: SWOT Analysis
Figure 7.7 Illumina: Overall Financials, 2013-2015
Figure 7.8 Illumina: Net Revenue by Business Segment, 2013-2015
Figure 7.9 Illumina: Revenue across Different Geographies, 2013-2015
Figure 7.10 Illumina: SWOT Analysis
Figure 7.11 LabCorp: Overall Financials, 2013-2015
Figure 7.12 LabCorp: Net Revenue by Business Segment, 2013-2015
Figure 7.13 LABCORP: SWOT Analysis
Figure 7.14 Natera Inc.: Overall Financials, 2013-2015
Figure 7.15 Natera Inc.: Revenue across Different Geographies, 2013-2015
Figure 7.16 Natera Inc.: SWOT Analysis
Figure 7.17 Quest Diagnostics: Overall Financials, 2013-2015
Figure 7.18 Quest Diagnostics: Net Revenue by Business Segments, 2013-2015
Figure 7.19 Quest Diagnostics: SWOT Analysis
Figure 7.20 Roche Holding: Overall Financials, 2013-2015
Figure 7.21 Roche Holding: Net Revenue by Business Segments, 2013-2015
Figure 7.22 Roche Holding: Revenue across Different Geographies, 2013-2015
Figure 7.23 Roche Holding: SWOT Analysis
Figure 7.24 Sequenom Inc.: Overall Financials, 2013-2015
Figure 7.25 Sequenom Inc.: Net Revenue by Business Segments, 2013-2015
Figure 7.26 Sequenom Inc.: SWOT Analysis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report